Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R01 HL105756
NHLBI NIH HHS - United States
PubMed
40533518
PubMed Central
PMC12283339
DOI
10.1038/s41588-025-02227-w
PII: 10.1038/s41588-025-02227-w
Knihovny.cz E-zdroje
- MeSH
- Alzheimerova nemoc * genetika epidemiologie mozkomíšní mok MeSH
- apolipoproteiny E genetika MeSH
- běloši * genetika MeSH
- biologické markery mozkomíšní mok MeSH
- celogenomová asociační studie MeSH
- genetická predispozice k nemoci * MeSH
- genetické rizikové skóre MeSH
- jednonukleotidový polymorfismus MeSH
- lidé MeSH
- multifaktoriální dědičnost * genetika MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
- Názvy látek
- apolipoproteiny E MeSH
- biologické markery MeSH
A polygenic score (PGS) for Alzheimer's disease (AD) was derived recently from data on genome-wide significant loci in European ancestry populations. We applied this PGS to populations in 17 European countries and observed a consistent association with the AD risk, age at onset and cerebrospinal fluid levels of AD biomarkers, independently of apolipoprotein E locus (APOE). This PGS was also associated with the AD risk in many other populations of diverse ancestries. A cross-ancestry polygenic risk score improved the association with the AD risk in most of the multiancestry populations tested when the APOE region was included. Finally, we found that the PGS/polygenic risk score captured AD-specific information because the association weakened as the diagnosis was broadened. In conclusion, a simple PGS captures the AD-specific genetic information that is common to populations of different ancestries, although studies of more diverse populations are still needed to better characterize the genetics of AD.
1st Department of Neurology Medical School Aristotle University of Thessaloniki Thessaloniki Greece
ACE Alzheimer Center Barcelona Universitat Internacional de Catalunya Barcelona Spain
Alzheimer Center Department of Neurology Erasmus MR Rotterdam the Netherlands
Alzheimer Research Center and Memory Clinic Andalusian Institute for Neuroscience Málaga Spain
Alzheimer's Centre Reina Sofia CIEN Foundation ISCIII Madrid Spain
Behavioral Sciences Division National Center for PTSD VA Boston Healthcare System Boston MA USA
Biomedica Research Group Centro de Estudios Clínicos Santiago Chile
BK FOUR Department of Integrative Biological Sciences Chosun University Gwangju Republic of Korea
Bordeaux Population Health Research Center INSERM Bordeaux UMR 1219 Bordeaux France
Bordeaux Population Health Research Center University Bordeaux Inserm Bordeaux France
Boston University and the NHLBI's Framingham Heart Study Boston MA USA
Center for Alzheimer's and Related Dementias NIH Bethesda MD USA
Center for Behavior Genetics of Aging University of California San Diego La Jolla CA USA
Center of Excellence for Stress and Mental Health VA San Diego Healthcare System San Diego CA USA
Centre for Neuropsychiatric Genetics and Genomics School of Medicine Cardiff University Cardiff UK
Centre for Precision Health Edith Cowan University Perth Western Australia Australia
Centro de Biología Molecular Severo Ochoa Madrid Spain
CHU de Bordeaux Pole Santé Publique Bordeaux France
Clinic of Neurology UH Alexandrovska Medical University Sofia Bulgaria
Complex Genetics of Alzheimer's Disease Group VIB Center for Molecular Neurology VIB Antwerp Belgium
Curtin Health Innovation Research Institute Curtin University Perth Western Australia Australia
DataTecnica LLC Washington DC USA
Deaprtment of Clinical and Experimental Sciences University of Brescia Italy Brescia Italy
Department of Biomedical Science Chosun University Gwangju Republic of Korea
Department of Biomedical Sciences University of Antwerp Antwerp Belgium
Department of Biomedical Sciences University of Cagliari Cagliari Italy
Department of Biomedical Surgical and Dental Sciences University of Milan Milan Italy
Department of Biostatistics Boston University School of Public Health Boston MA USA
Department of Biostatistics University of Washington Seattle WA USA
Department of Cardiovascular Sciences University of Leicester Leicester UK
Department of Clinical Biochemistry Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Clinical Genetics VU University Medical Centre Amsterdam the Netherlands
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Clinical Sciences and Community Health University of Milan Milan Italy
Department of Continuity of Care and Frailty ASST Spedali Civili Brescia Brescia Italy
Department of Epidemiology and Biostatistics Case Western Reserve University Cleveland OH USA
Department of Epidemiology Boston University Boston MA USA
Department of Epidemiology ErasmusMC Rotterdam the Netherlands
Department of Genome Sciences University of Washington Seattle WA USA
Department of Geriatric Medicine Oslo University Hospital Oslo Norway
Department of Geriatric Psychiatry University Hospital of Psychiatry Zürich Zurich Switzerland
Department of Hematology and Stem Cell Transplant Vito Fazzi Hospital Lecce Italy
Department of Medical and Molecular Genetics Indiana University Indianapolis IN USA
Department of Medicine Boston University Boston MA USA
Department of Medicine University of Washington Seattle WA USA
Department of Neurology Amitié Hospital Bangui Central African Republic
Department of Neurology and Psychiatry Clínica Alemana Santiago Chile
Department of Neurology Bordeaux University Hospital Bordeaux France
Department of Neurology Boston University Boston MA USA
Department of Neurology Boston University School of Medicine Boston MA USA
Department of Neurology Brazzaville University Hospital Brazzaville Republic of Congo
Department of Neurology Columbia University New York NY USA
Department of Neurology Hospital Universitario Donostia San Sebastian Spain
Department of Neurology UH Alexandrovska Medical University Sofia Bulgaria
Department of Neuroscience Mount Sinai School of Medicine New York NY USA
Department of Neuroscience Rita Levi Montalcini University of Torino Turin Italy
Department of Neuroscience Università Cattolica del Sacro Cuore Rome Italy
Department of Ophthalmology Boston University Boston MA USA
Department of Psychiatry and Psychotherapy University Medical Center Goettingen Goettingen Germany
Department of Psychiatry Boston University Chobanian and Avedisian School of Medicine Boston MA USA
Department of Psychiatry Federal University of Minas Gerais Belo Horizonte Minas Geraes Brazil
Department of Psychiatry Old Age Psychiatry Lausanne University Hospital Lausanne Switzerland
Department of Psychiatry University of California San Diego La Jolla CA USA
Department of Psychiatry Washington University School of Medicine St Louis MO USA
Department of Public Health and Caring Sciences Geriatrics Uppsala University Uppsala Sweden
Department of Public Health and Carins Sciences Geriatrics Uppsala University Uppsala Sweden
Department of Radiology and Biomedical Imaging University of California San Francisco CA USA
Department of Radiology ErasmusMC Rotterdam the Netherlands
Department of Radiology Indiana University Indianapolis IN USA
Department of Surgery Federal University of Minas Gerais Belo Horizonte Minas Geraes Brazil
Depatment of Neurology Columbia University New York NY USA
Division of Aging Brigham and Women's Hospital Harvard Medical School Boston MA USA
Division of Mental Health and Addiction NORMENT Centre Oslo University Hospital Oslo Norway
Dr John T Macdonald Foundation Department of Human Genetics University of Miami Miami FL USA
Faculty of Medicine University of Lisbon Lisbon Portugal
Faculty of Medicine University of Oslo Oslo Norway
Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
Genetics of Neurodegenerative Diseases Unit IIB Sant Pau Barcelona Spain
Geriatrics Section Clinical Hospital University of Chile Santiago de Chile Chile
German Center for Neurodegenerative Diseases Berlin Germany
German Center for Neurodegenerative Diseases Bonn Germany
German Center for Neurodegenerative Diseases Goettingen Germany
German Center for Neurodegenerative Diseases Magdeburg Germany
German Center for Neurodegenerative Diseases Munich Germany
Geroscience Center for Brain Health and Metabolism Santiago Chile
Gertrude H Sergievsky Center Columbia University New York NY USA
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases San Antonio TX USA
Graduate School of Frontier Science University of Tokyo Tokyo Japan
High Institute of Biotechnology University of Monastir Monastir Tunisia
Hong Kong Center for Neurodegenerative Diseases Hong Kong China
Hôpital Broca Université de Paris EA 4468 APHP Paris France
Hospital Interzonal General de Agudos Eva Perón Buenos Aires Argentina
Institut de Recerca Biomedica de Lleida Lleida Spain
Institut du Cerveau Paris Brain Institute ICM Paris France
Institute for Regenerative Medicine University of Zürich Zurich Switzerland
Institute for Stroke and Dementia Research University Hospital LMU Munich Munich Germany
Institute for Urban Public Health University Hospital Essen University Duisburg Essen Essen Germany
Institute of Biomedicine University of Eastern Finland Kuopio Finland
Institute of Clinical Medicine Neurology University of Eastern Finland Kuopio Finland
Institute of Clinical Medicine University of Oslo Oslo Norway
Institute of Neurology Catholic University of the Sacred Heart Rome Italy
Instituto de Biomedicina de Sevilla IBiS Hospital Universitario Virgen de Valme Sevilla Spain
Instituto de Investigacion Sanitaria 'Hospital la Paz' Madrid Spain
Instituto de Investigación Sanitaria del Principado de Asturias Oviedo Spain
Instituto Nacional de Geriatría Santiago Chile
International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic
Interuniversity Center for Healthy Aging RED21993 Santiago de Chile Chile
IRCCS Fondazione Don Carlo Gnocchi Florence Italy
Krembil Brain Institute University Health Network Toronto Ontario Canada
Laboratorio de Genética Hospital Universitario Central de Asturias Oviedo Spain
Laboratory of Neurogenetics NIH Bethesda MD USA
Laboratory of Neuropsychiatry IRCCS Santa Lucia Foundation Rome Italy
Latin American Institute for Brain Health Universidad Adolfo Ibanez Santiago Chile
Medical Science Department iBiMED Aveiro Portugal
Munich Cluster for Systems Neurology Munich Germany
Neurodegenerative Diseases Unit Fondazione IRCCS Ca' Granda Ospedale Policlinico Milan Italy
NeuroGenomics and Informatics Center Washington University School of Medicine St Louis MO USA
Neurological Tissue Bank Biobanc Hospital Clinic FRCB IDIBAPS Barcelona Spain
Neurology IRCCS San Gerardo dei Tintori Monza and University of Milano Bicocca Milano Italy
Neurology Service Hospital del Salvador Santiago Chile
Neurology Service Marqués de Valdecilla University Hospital Santander Spain
Neurology Unit IRCCS Fondazione Policlinico Universitario A Gemelli Rome Italy
Neuroscience Center Zurich University of Zurich and ETH Zurich Zurich Switzerland
Neurosciences Area Instituto Biogipuzkoa San Sebastian Spain
Niigata University Brain Research Institute Niigata Japan
Norwegian Centre for Ageing and Health Vestfold Hospital Trust Tønsberg Norway
Nuffield Department of Population Health Oxford University Oxford UK
Past Director Dementia Unit University of Parma Parma Italy
Research Center National Center for Geriatrics and Gerontology Obu Japan
Studies in Neuroscience and Complex Systems Unit CONICET HEC UNAJ Buenos Aires Argentina
Studies in Neuroscience and Complex Systems Unit CONICET HEC UNAJ Santiago Chile
The Germans Trias i Pujol Research Institute Badalona Spain
The John P Hussman Institute for Human Genomics University of Miami Miami FL USA
Translational Health Sciences Bristol Medical School University of Bristol Bristol UK
UK Dementia Research Institute Cardiff University Cardiff UK
Unit for Hereditary Dementias Theme Aging Karolinska University Hospital Solna Stockholm Sweden
Unitat de Genètica Molecular Institut de Biomedicina de València CSIC Valencia Spain
Unitat Trastorns Cognitius Hospital Universitari Santa Maria de Lleida Lleida Spain
Universidad Autónoma de Madrid Madrid Spain
Université Paris Saclay CEA Centre National de Recherche en Génomique Humaine Evry France
VA San Diego Healthcare System San Diego CA USA
Zurich Center for Integrative Human Physiology University of Zurich Zurich Switzerland
Zobrazit více v PubMed
Osterman, M. D., Kinzy, T. G. & Bailey, J. N. C. Polygenic risk scores. PubMed
Kachuri, L. et al. Principles and methods for transferring polygenic risk scores across global populations. PubMed PMC
Gatz, M. et al. Role of genes and environments for explaining Alzheimer disease. PubMed
Baker, E. & Escott-Price, V. Polygenic risk scores in Alzheimer’s disease: current applications and future directions. PubMed PMC
Desikan, R. S. et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PubMed PMC
Sabuncu, M. R. et al. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. PubMed PMC
Mormino, E. C. et al. Polygenic risk of Alzheimer disease is associated with early- and late-life processes. PubMed PMC
Xicota, L. et al. Association of APOE-independent Alzheimer disease polygenic risk score with brain amyloid deposition in asymptomatic older adults. PubMed PMC
Sleegers, K. et al. A 22-single nucleotide polymorphism Alzheimer’s disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42. PubMed
Hong, S. et al. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD multimodal biomarker discovery dataset. PubMed PMC
Clark, K., Leung, Y. Y., Lee, W.-P., Voight, B. & Wang, L.-S. Polygenic risk scores in Alzheimer’s disease genetics: methodology, applications, inclusion, and diversity. PubMed PMC
Sariya, S. et al. Polygenic risk score for Alzheimer’s disease in Caribbean Hispanics. PubMed PMC
Jung, S.-H. et al. Transferability of Alzheimer disease polygenic risk score across populations and its association with Alzheimer disease-related phenotypes. PubMed PMC
Dalmasso, M. C. et al. The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer’s disease. PubMed PMC
Kikuchi, M. et al. Polygenic effects on the risk of Alzheimer’s disease in the Japanese population. PubMed PMC
Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. PubMed PMC
Koyama, S. et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. PubMed
Lennon, N. J. et al. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. PubMed PMC
Keaton, J. M. et al. Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. PubMed PMC
Ge, T. et al. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. PubMed PMC
Xiang, R. et al. Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. PubMed PMC
Jansen, I. E. et al. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers. PubMed PMC
Logue, M. W., Dasgupta, S. & Farrer, L. A. Genetics of Alzheimer’s disease in the African American population. PubMed PMC
Miyashita, A., Kikuchi, M., Hara, N. & Ikeuchi, T. Genetics of Alzheimer’s disease: an East Asian perspective. PubMed PMC
Kunkle, B. W. et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African Genome Resources Panel: a meta-analysis. PubMed PMC
Lake, J. et al. Multi-ancestry meta-analysis and fine-mapping in Alzheimer’s disease. PubMed PMC
Shigemizu, D. et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk. PubMed PMC
Frisoni, G. B. et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. PubMed PMC
Wang, Y. et al. Polygenic prediction across populations is influenced by ancestry, genetic architecture, and methodology. PubMed PMC
Smith, J. L. et al. Multi-ancestry polygenic risk score for coronary heart disease based on an ancestrally diverse genome-wide association study and population-specific optimization. PubMed PMC
Khan, A. et al. Genome-wide polygenic score to predict chronic kidney disease across ancestries. PubMed PMC
Naslavsky, M. S. et al. Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample. PubMed PMC
Rajabli, F. et al. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PubMed PMC
Bussies, P. L. et al. Use of local genetic ancestry to assess TOMM40-523’ and risk for Alzheimer disease. PubMed PMC
Rajabli, F. et al. A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s disease in African Ancestry. PubMed PMC
Nagao, Y. Contribution of rare variants to heritability of a disease is much greater than conventionally estimated: modification of allele distribution model. PubMed
Das, S. et al. Next-generation genotype imputation service and methods. PubMed PMC
Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. PubMed PMC
Chen, C.-Y. et al. Improved ancestry inference using weights from external reference panels. PubMed PMC
Le Guen, Y. et al. Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. PubMed PMC
Fang, H. et al. Harmonizing genetic ancestry and self-identified race/ethnicity in genome-wide association studies. PubMed PMC
Abraham, G., Qiu, Y. & Inouye, M. FlashPCA2: principal component analysis of Biobank-scale genotype datasets. PubMed
Nicolas, A. Transferability of European-derived Alzheimer’s disease polygenic risk scores across multi-ancestry populations. PubMed PMC
Ruan, Y. et al. Improving polygenic prediction in ancestrally diverse populations. PubMed PMC
Ma, Y. & Zhou, X. Genetic prediction of complex traits with polygenic scores: a statistical review. PubMed PMC
Kurniansyah, N. et al. Evaluating the use of blood pressure polygenic risk scores across race/ethnic background groups. PubMed PMC
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. PubMed PMC
Hao, L. et al. Development of a clinical polygenic risk score assay and reporting workflow. PubMed PMC
Lee, S. H., Goddard, M. E., Wray, N. R. & Visscher, P. M. A better coefficient of determination for genetic profile analysis. PubMed
Choi, S. W., Mak, T. S.-H. & O’Reilly, P. F. Tutorial: a guide to performing polygenic risk score analyses. PubMed PMC
Lee, S. H. & Wray, N. R. Novel genetic analysis for case-control genome-wide association studies: quantification of power and genomic prediction accuracy. PubMed PMC
Baker, E. et al. What does heritability of Alzheimer’s disease represent? PubMed PMC
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. PubMed PMC